|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.110 CNY | -2.29% |
|
+2.00% | -0.20% |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| 06-11 | Jointown Pharma Issues 1 Billion Yuan in Asset-Backed Securities | MT |
| Market Cap | 25.48B 3.77B 3.3B 3.04B 2.8B 5.27B 362B 5.41B 36.36B 14.31B 178B 14.14B 13.83B 611B | P/E 2026 * |
10.9x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 21.16B 3.13B 2.74B 2.53B 2.33B 4.38B 301B 4.49B 30.19B 11.88B 148B 11.74B 11.48B 508B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.09% | Yield 2027 * | 4.36% |
| 1 day | -2.29% | ||
| 1 week | +2.00% | ||
| Current month | +8.96% | ||
| 1 month | +5.80% | ||
| 3 months | -2.85% | ||
| 6 months | -2.67% | ||
| Current year | -0.20% |
| 1 week | 4.98 |  | 5.28 |
| 1 month | 4.48 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei He
CEO | Chief Executive Officer | 40 | 22/04/2022 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 14/11/2023 |
Xi Zhang
IRC | Investor Relations Contact | - | 22/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gu Liang Tang
BRD | Director/Board Member | 64 | 04/11/2020 |
Bao Lin Liu
CHM | Chairman | 73 | 31/10/2008 |
Zhao Nian Liu
BRD | Director/Board Member | 66 | 15/11/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/06/24 | Buy | Chairman | 19,056 | 0.0005% | ||
| 07/06/24 | Buy | Director | 13,583,444 | 0.3475% | ||
| 07/06/24 | Buy | Director | 199,630 | 0.0051% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.29% | +2.00% | -4.49% | -6.59% | 3.76B | |
| +0.01% | +4.40% | +18.54% | +104.90% | 98.51B | |
| -0.09% | -3.09% | +43.22% | +145.22% | 53.52B | |
| -0.34% | +3.90% | +4.27% | +266.25% | 23.53B | |
| -2.52% | +2.98% | -12.49% | -21.65% | 8.25B | |
| -5.82% | +2.45% | -32.81% | -32.05% | 7.79B | |
| -1.35% | +5.02% | -6.54% | -27.10% | 6.99B | |
| +2.44% | +0.89% | +26.58% | +30.99% | 6.31B | |
| +0.79% | +2.77% | -0.39% | +25.12% | 5.51B | |
| +1.62% | +8.06% | +17.08% | +21.47% | 3.59B | |
| Average | -0.76% | +2.88% | +5.30% | +50.66% | 21.78B | |
| Weighted average by Cap. | -0.32% | +2.47% | +18.58% | +110.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.09B 21.97B 20.29B 18.66B 35.11B 2,415B 36.03B 242B 95.36B 1,184B 94.21B 92.14B 4,075B | 180B 26.57B 23.27B 21.48B 19.76B 37.18B 2,558B 38.16B 257B 101B 1,254B 99.78B 97.58B 4,315B |
| Net income | 2.36B 348M 305M 281M 259M 487M 33.51B 500M 3.36B 1.32B 16.43B 1.31B 1.28B 56.54B | 2.56B 378M 331M 306M 281M 529M 36.39B 543M 3.65B 1.44B 17.84B 1.42B 1.39B 61.4B |
| Net Debt | -4.32B -638M -559M -516M -475M -893M -61.46B -917M -6.17B -2.43B -30.13B -2.4B -2.34B -104B | -5.04B -745M -653M -602M -554M -1.04B -71.74B -1.07B -7.2B -2.83B -35.17B -2.8B -2.74B -121B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | CN¥5.110 | -2.29% | 47,920,079 |
| 16/07/26 | CN¥5.230 | +1.36% | 57,762,090 |
| 15/07/26 | CN¥5.160 | -0.96% | 53,342,812 |
| 14/07/26 | CN¥5.210 | +2.96% | 77,010,061 |
| 13/07/26 | CN¥5.060 | +1.00% | 46,963,570 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
